Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Author(s): Allen Loyd V Jr, Williams LaVonn A
Issue: Jul/Aug 2012 - Volume 16, Number 4
View All Articles in Issue
Page(s): 294-298
Note: Electronic version includes supplemental material.
Download in electronic PDF format for $75
Abstract: Drug shortages, which are at an all-time high, and discontinued drugs have patients, physicians, and pharmacists scrambling for answers to the problem of unavailable drugs. Needless to say these problems have created unnecessary discomfort for patients and have put patients in life and death situations. This article discusses some of the possible reasons for the problems and how they affect patients and those healthcare providers who are dedicated to the medical treatment of patients.
Related Keywords:
drug shortages, discontinued drugs, patient care, U.S. Food and Drug Administration, FDA
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Allen Loyd V Jr, Williams LaVonn A
|
Jul/Aug 2012
Pg. 294-298
|
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare
Allen Loyd V Jr, Williams LaVonn A
|
Jul/Aug 2012
Pg. 350-351
|
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 356
|
PreScription: Discontinued Drugs and Drug Shortages
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 92
|
The Role of Compounding Pharmacists During Drug Shortages
Ofei Kelvin
|
Jul/Aug 2022
Pg. 298-301
|
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 351
View Sample |
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Lyon Joanna
|
Nov/Dec 2012
Pg. 456-460
|
Allowing Compounding Pharmacies to Address Drug Shortages
Broughel James
|
Mar/Apr 2022
Pg. 100-109
|
PreScription: Drug Shortages and Discontinued Drugs
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 268
|
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 487-488
|
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
|
Jul/Aug 2015
Pg. 303-305
|
Marketing: Drug Shortages and Discontinued Drugs: Marketing Techniques that Compounding Pharmacists Can Use to Advise and Serve Their Patients
Moore Renee
|
Sep/Oct 2012
Pg. 394-395
|
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed
Brunner Scott
|
Jul/Aug 2020
Pg. 296-297
|
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
|
Jan/Feb 2020
Pg. 30-36
|
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 389-390
|
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake
|
Sep/Oct 2015
Pg. 377-380
|
PreScription: Compounding for Drug Shortages
Allen Loyd V Jr
|
May/Jun 2013
Pg. 180
|
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line
Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A
|
Jan/Feb 2019
Pg. 32-33
|
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
|
Nov/Dec 2011
Pg. 526-527
|
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List")
Allen Loyd V Jr, Ashworth Lisa D
|
Jan/Feb 2005
Pg. 44-46
|
| Return to Top |
